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Abstract
Background: Portugal has the highest prevalence rate of HIV infection in Western Europe. The proportion of patients
with a late diagnosis, carried out in full-blown AIDS stage, remains high. Skin and mucous membrane manifestations are
not rare in these patients.
Objective: A demographic, clinical, and laboratorial characterization of patients with de novo HIV infection diagnosis
made in the Department of Dermatology and Venereology of a central hospital in Lisbon, Portugal.
Methods: Retrospective review of medical records of adult patients newly diagnosed with HIV infection (reactive
immunoassay for antibodies to HIV-1/HIV-2 or HIV p24 antigen) in the Dermatology and Venereology Department of
a Portuguese central hospital in the period between January 2005 and December 2013.
Results: During the study period, 97 new cases were diagnosed, 70 men and 27 women. The median age at diagnosis
was 36 years. Of the total, 50 cases were diagnosed with a concomitant sexually transmitted infection (STI), more
frequently syphilis and ano-genital HPV infection. The remaining 47 patients were diagnosed with other dermatological
conditions such as prurigo nodularis, psoriasis, and Kaposi’s sarcoma. The duration of complaints that lead to medical
attention ranged from <1 week to 8 years, being significantly lower in patients diagnosed with a concomitant STI
(p< 0.01). Basal viral load was also lower in this group of patients (p< 0.05). Of all the new diagnosed cases, 80% of
patients are currently retained in care.
Conclusion: This study grants a descriptive overview of de novo HIV infection diagnoses performed by dermatovener-
eologists in a central hospital in Lisbon, Portugal. As in the past, the importance of Dermato–Venereology for HIV
infection diagnosis remains present in daily clinical practice.
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Introduction
In 1982, the Centers for Disease Control and
Prevention put forward the deﬁnition of a new disease
entity, the acquired immunodeﬁciency syndrome
(AIDS), based on increasing numbers of reports of
immunodeﬁciency-associated disease in previously
healthy young men.1 In the next years, when it
became evident that HIV was primarily sexually trans-
mitted and that more than 95% of patients had skin
manifestations in the course of their disease,2,3 derma-
tologists throughout the world diagnosed and treated
many patients with HIV infection or/and AIDS.
Since then, much has changed, and in countries
where antiretroviral drugs are widely available, HIV/
AIDS changed from a fatal disease to a chronic disease
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requiring lifelong medication and medical management
in many ways similar to the general population.4,5
HIV infection is a major public health concern in
Europe, characterized by continuously rising case num-
bers. The average rate of newly diagnosed HIV infec-
tions in Europe was 5.7 cases per 100,000 in 2011.6 The
average rate of newly diagnosed HIV infections in
Portugal is considerably higher, 13.6 cases per 100,000
in 2013.7 On the other hand, as far as AIDS is con-
cerned, diagnoses in Europe have been steadily declin-
ing (1.2 cases per 100,000 in 2010), but in countries such
as Latvia (4.8 cases per 100,000), Portugal (2.8 cases per
100,000), Spain (1.8 cases per 100,000), and Estonia
(2.8 cases per 100,000), these rates are still hauntingly
high.6 So, the global impact of new HIV/AIDS diag-
noses in Europe is still very worrisome. In order to
optimize early HIV detection, the HIV in Europe
Initiative has proposed a new approach – the indicator
condition-guided HIV testing – encouraging physicians
to oﬀer an HIV test to individual patients with certain
medical conditions.8–10
In a world where prompt HIV diagnosis and treat-
ment are associated with increased longevity and
reduced transmission,11,12 the paradigm towards this
disease has shifted from ‘‘damage control’’ to ‘‘the ear-
lier, the better’’. Besides treating side eﬀects of anti-
retroviral drug therapies and helping to curb its
spread by control of other sexually transmitted infec-
tions (STIs), does the dermatovenerologist still contrib-
ute to the diagnosis of HIV infection in high resource
settings?
The objective of the present study is to elaborate a
demographic, clinical, and laboratorial characterization
of patients with de novo HIV infection diagnosis made
in the Department of Dermatology and Venereology of
a central hospital in Portugal.
Materials and methods
This study is a retrospective review of medical records
of patients older than 16 years who were newly diag-
nosed with HIV infection in General Dermatology
Clinic, Urgent Care Dermatology Clinic, Sexually
Transmitted Infections Clinic and Dermatology
Inpatient Ward of Hospital de Curry Cabral in the
period between January 2005 and December 2013 (9
years).
Hospital de Curry Cabral is a central hospital in
Lisbon, Portugal, integrated in Centro Hospitalar de
Lisboa Central (‘‘Lisbon’s Central Hospital Group’’),
a group of six public cooperating hospitals. General
Dermatology Clinic receives patients from local general
practitioners and other medical specialties in Centro
Hospitalar de Lisboa Central (by appointment only).
Urgent Care Dermatology Clinic receives patients
from local general practitioners, the emergency depart-
ment, and other medical specialties for immediate der-
matological care. STI Clinic is a walk-in sexual health
clinic and no referral from other physician is needed.
Dermatology inpatient ward receives admitted patients
from all Dermatology Clinics and emergency depart-
ment. In Portugal, as in most European countries,
Dermato-Venereology is a medical-surgical specialty
that provides both dermatological and STI care. Thus,
not only are dermatovenereologists responsible for the
Dermatology Clinics but also for the STI Clinic and
both areas of care are practised in an integrated way.
Laboratorial screening was made with reactive
chemiluminescent microparticle immunoassay for anti-
bodies to HIV-1, HIV-2, or HIV p24 antigen –
ARCHITECT HIV Ag/Ab Combo, Abbot.
According to institution protocol, all positive screening
results are conﬁrmed by HIV-1 and HIV-2 Western
Blot on a second serum specimen. The term ‘‘de novo
HIV infection’’ refers to newly diagnosed HIV infec-
tions in patients that were until that moment unaware
of having this condition.
Statistical analysis was performed using Chi-squared
test, Fisher’s exact test and Student’s t test. Signiﬁcance
was deﬁned for p< 0.05.
Results
During the period from January 2005 to December 2013
(nine years), the serology for HIV1/2 was requested 3833
times by dermatovenereologists in the Dermatology and
Venereology Department. A total of 97 individuals
tested positive for HIV (3%), of which 93 were HIV-1
and 4 HIV-2 infections. The yearly average of new HIV
diagnoses in this department was 11 cases per year.
When considering the newly diagnosed HIV patients
(n¼ 97), 45 attended the STI Clinic (46%), 27 the GD
Clinic (28%), 21 the UCD Clinic (22%), and 4 were
admitted to the DIW (4%).
There were 70 male (72%) and 27 female patients
(28%). As for the place of birth, 49 patients (51%)
were born in Portugal and the remaining 48 patients
were migrants, of which 38 from African countries.
About half of the patients (n¼ 50/97) were diag-
nosed with a concomitant STI (Figure 1). In this
group, the top ﬁve conditions were recent or secondary
syphilis (18 cases), ano-genital human papilloma virus
(HPV) infection (13 cases), Neisseria gonorrhoeae infec-
tion (5 cases), ano-genital herpes simplex virus (HSV)
infection (4 cases), and Molluscum contagiosum infec-
tion (4 cases). Figure 2 includes all STI diagnosis made
in this group.
For patients diagnosed with a non-STI dermato-
logical condition (n¼ 47/97, Figure 1), the top ﬁve diag-
noses were prurigo nodularis (seven cases), psoriasis
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(ﬁve cases), Kaposi’s sarcoma (four cases), varicella-
zoster virus (VZV) infection (four cases), and oral
HSV infection (three cases). The full list is extensive
and is summarized in Figure 3.
The duration of complaints that lead to dermatove-
nereological attention ranged from<1 week to 8 years
(median 12 weeks). For patients diagnosed with a con-
comitant STI, the median duration of complaints was
4 weeks, whereas it was 16 weeks for those with other
dermatological diagnoses (p< 0.01).
Most diagnosed patients (85%) fall in the age group
between 21 and 50 years old (range 17 to 73 years old),
Figure 1. Distribution of concomitant dermatovenereological diagnoses in patients with de novo HIV infection identified in the
Dermatology and Venereology Department of Hospital de Curry Cabral, Lisbon (Portugal) between 2005 and 2013 (n¼ 97).
Figure 2. Distribution of concomitant STI diagnosed in patients with de novo HIV infection (n¼ 50).
*Nine cases of secondary syphilis and nine of recent syphilis.
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with a median age at diagnosis of 36 years old. Patients
diagnosed with a STI were younger than those diag-
nosed with other conditions (median age 36 and 46
years old, respectively, p< 0.01).
Overall, 33 (34%) patients had an initial CD4 cell
count lower than 200 cells/mm3, 24 (25%) had between
200–500 cells/mm3 and 17 (18%) had over 500 cells/
mm3 (data not available for 23 patients). There was
no signiﬁcant diﬀerence in CD4 cell count of patients
diagnosed with a concomitant STI when compared to
those having a non-STI condition (p¼ 0.259).
Data on basal viral load were available for 71
patients, of which 23 had over 1000 copies/mL, while
48 patients had less than that value. Of note, patients
diagnosed with an STI had lower viral load count than
those having a non-STI diagnosis (p< 0.01).
As far as follow-up is concerned, 12% of all de novo
HIV diagnosed patients (12/97 cases) never returned
after the initial GD/UCD/STI appointment (even
after telephone summoning). These patients were not
informed of the diagnosis by the dermatovenereologist,
nor were they referred to Infectious Diseases (ID)
Clinic. All the patients that did return to the depart-
ment (88%, i.e. 85/97 cases) were informed of the diag-
nosis by their dermatovenereologist and were referred
to ID Clinic; 8% (7/97 cases) never attended that
Clinic. The total ‘‘lost-to-care’’ patients were 19: 11
patients from STI Clinic and 8 patients from
Dermatology Clinics. Overall, the retention in care
rate is of 80% (78/97 cases).
Discussion
Tschachler has recently reminded us of the importance
of Dermato-Venereology in the clinical management of
HIV patients.3 Concrete data regarding the role of der-
matovenereologists in diagnosing new HIV infection
cases today in Europe are unavailable; current data
from Portugal concerning this matter will be the
object of this discussion.
A total of 97 de novo HIV infection diagnoses were
made, which corresponds to an overall 3% positivity
rate regarding the 3833 times dermatovenereologists
requested HIV testing. Opposed to what might seem
expected at ﬁrst glance, most new HIV diagnoses in
this Department were made in the Dermatology
Clinics/DIW (54%) and not in the STI Clinic (46%).
However, one must take into account that STI were
also diagnosed at Dermatology Clinics, making con-
comitant STI the most representative diagnostic
Figure 3. Distribution of non-STI dermatoses identified in patients with de novo HIV infection (n¼ 47).
*Granuloma annulare, eosinophilic folliculitis (one case each).
**Tinea corporis, impetigo, recurrent erysipelas (one case each).
***Seborrhoeic dermatitis, generalized dermatitis, lichen sclerosus, lichen simplex cronicus (one case each).
****B-cell cutaneous lymphoma, oral florid papillomatosis (one case each).
*****Perniosis, porphyria cutanea tarda.
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group (52%). When comparing these two groups
regarding the duration of complaints that lead to der-
matovenereological attention, the median duration of
the clinical picture was signiﬁcantly shorter for STI
diagnoses (4 weeks) than for the remaining patients
(16 weeks) (p< 0.01). Analyzing the concomitant con-
ditions in each group can help justify this diﬀerence in
the duration of complaints: the second group of
patients were diagnosed mostly cutaneous manifest-
ations of advanced immunosuppression, while the STI
group had just concomitant STIs. These data conﬁrm
the importance of testing for HIV all attendees present-
ing with an STI. From our experience, exuberant, dif-
ﬁcult to treat or atypical presentations of diseases like
prurigo nodularis, herpetic infections or psoriasis should
also lead to promptly exclude an underlying HIV infec-
tion. The re-emergence of syphilis and frequent co-
infection with HIV must also be highlighted. It is not
surprising to see that patients diagnosed with non-STI
conditions had higher median number of HIV-1 RNA
copies/mL (p< 0.05) when compared to patients diag-
nosed in STI Clinics; in fact, the median CD4 T cell
count tended to be lower in the non-STI conditions
group and most of these cases were AIDS diagnoses.
Comparing the top conditions observed in our
Department with the indicator conditions in the HIV
in Europe Initiative Guidance,8 several common diag-
noses can be found (including Kaposi’s sarcoma, her-
petic infections, severe or recalcitrant psoriasis or STI).
Champenois et al.13 also show that under current
screening policies, missed opportunities for HIV testing
remain unacceptably high in France, recognizing that
HIV testing should be oﬀered to patients presenting
with HIV-related cutaneous conditions and/or STI is
pointed as crucial to make earlier HIV diagnoses. In
our opinion, both the public and the medical commu-
nity in general are not as aware as they should be
regarding HIV-related cutaneous diseases. This point
may explain the longer duration of complaints and
more advanced immunosuppression found in the
patients diagnosed in the Dermatology Clinics/DIW
as a non-dermatovenereologist doctor had previously
observed and referred all patients.
Prurigo nodularis was the most frequent diagnosis in
our series. Recent studies by Iking et al.14 (Germany)
and Tan and Tey15 (Singapore) evaluated series of prur-
igo nodularis patients regarding coexisting diseases and
no case of HIV infection was found.14,15 Magand
et al.16 (French Guyana), however, showed that prurigo
nodularis was predictive of advanced immunosuppres-
sion in their case series. Prurigo nodularis was not
included in the HIV in Europe Initiative Guidance
Guidelines and maybe these new data will draw the
whole medical community’s attention to this dermato-
logical condition.
Most of the newly diagnosed HIV individuals were
male, both in STI and non-STI groups (70% in each
group). It is known that the major attendees of STI
Clinic are men, and that asymptomatic STIs are more
frequent in women and one could easily speculate about
other possible motifs to justify these numbers. Whatever
reasons for this diﬀerence might there be, it is interesting
to notice this fact and perhaps have a lower index of
suspicion for males, should this information be con-
ﬁrmed in other studies in dermatology clinics.
The high number of new diagnoses in migrant
patients (50% of all cases) must be highlighted. In
fact, considering the global numbers of new cases in
Europe, the ﬁgure in some populations such as those
from sub-Saharan African countries is a group of spe-
cial concern due to median lower CD4 T cell counts at
the time of diagnosis and higher percentage of AIDS
cases.6 The population served by our Department is
mainly urban (center of Lisbon) and culturally and eth-
nically diverse, including many immigrants from the
Portuguese-speaking African countries. Whether the
HIV infection was acquired in Africa or in Europe is
a matter of controversy and beyond the point of dis-
cussion in this paper; instead, we wonder if this more
advanced state of immunosuppression due to HIV in
this population could be justiﬁed by social fragility and
diﬃcult access to health care. In a fast-changing
Europe, socially and culturally enriched by intense
migration ﬂows, the relevance of these ﬁndings could
not be more contemporary.
Of all the new HIV patients diagnosed by dermato-
venereologists in the mentioned period, the retention in
care rate is of 80% (78/97 cases), similar to other recent
European publications.17
In our experience, dermatovenereologists still play a
pivotal role in the clinical management of HIV-infected
patients, from the earliest phase of diagnosis to the treat-
ment period, and also in the promotion of healthy sexual
practices. In a dynamic and changing world, struggling
against the HIV/AIDS epidemic, the importance of
Dermato-Venereology holds an undeniable position.
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